132 related articles for article (PubMed ID: 21359415)
1. PRAME gene expression profile in medulloblastoma.
Vulcani-Freitas TM; Saba-Silva N; Cappellano A; Cavalheiro S; Toledo SR
Arq Neuropsiquiatr; 2011 Feb; 69(1):9-12. PubMed ID: 21359415
[TBL] [Abstract][Full Text] [Related]
2. Adoptive Immunotherapy Using PRAME-Specific T Cells in Medulloblastoma.
Orlando D; Miele E; De Angelis B; Guercio M; Boffa I; Sinibaldi M; Po A; Caruana I; Abballe L; Carai A; Caruso S; Camera A; Moseley A; Hagedoorn RS; Heemskerk MHM; Giangaspero F; Mastronuzzi A; Ferretti E; Locatelli F; Quintarelli C
Cancer Res; 2018 Jun; 78(12):3337-3349. PubMed ID: 29615432
[TBL] [Abstract][Full Text] [Related]
3. Cancer-testis antigen expression in synovial sarcoma: NY-ESO-1, PRAME, MAGEA4, and MAGEA1.
Iura K; Maekawa A; Kohashi K; Ishii T; Bekki H; Otsuka H; Yamada Y; Yamamoto H; Harimaya K; Iwamoto Y; Oda Y
Hum Pathol; 2017 Mar; 61():130-139. PubMed ID: 27993576
[TBL] [Abstract][Full Text] [Related]
4. ASPM gene expression in medulloblastoma.
Vulcani-Freitas TM; Saba-Silva N; Cappellano A; Cavalheiro S; Marie SK; Oba-Shinjo SM; Malheiros SM; de Toledo SR
Childs Nerv Syst; 2011 Jan; 27(1):71-4. PubMed ID: 20694558
[TBL] [Abstract][Full Text] [Related]
5. Cancer-testis (CT) antigen expression in medulloblastoma.
Oba-Shinjo SM; Caballero OL; Jungbluth AA; Rosemberg S; Old LJ; Simpson AJ; Marie SK
Cancer Immun; 2008 Apr; 8():7. PubMed ID: 18426187
[TBL] [Abstract][Full Text] [Related]
6. PRAME Expression and Its Clinical Relevance in Hodgkin's Lymphoma.
Ercolak V; Paydas S; Bagir E; Ergin M; Seydaoglu G; Celik H; Yavu B; Tanriverdi K; Gunaldi M; Afsar CU; Duman BB
Acta Haematol; 2015; 134(4):199-207. PubMed ID: 26044287
[TBL] [Abstract][Full Text] [Related]
7. OTX1 and OTX2 Genes in Medulloblastoma.
Figueira Muoio VM; Uno M; Oba-Shinjo S; da Silva R; Araújo Pereira BJ; Clara C; Matushita H; Marie SNK
World Neurosurg; 2019 Jul; 127():e58-e64. PubMed ID: 30797919
[TBL] [Abstract][Full Text] [Related]
8. Overexpressed TP73 induces apoptosis in medulloblastoma.
Castellino RC; De Bortoli M; Lin LL; Skapura DG; Rajan JA; Adesina AM; Perlaky L; Irwin MS; Kim JY
BMC Cancer; 2007 Jul; 7():127. PubMed ID: 17626635
[TBL] [Abstract][Full Text] [Related]
9. Digital expression profile of immune checkpoint genes in medulloblastomas identifies CD24 and CD276 as putative immunotherapy targets.
Marques RF; Moreno DA; da Silva L; Leal LF; de Paula FE; Santana I; Teixeira G; Saggioro F; Neder L; Junior CA; Mançano B; Reis RM
Front Immunol; 2023; 14():1062856. PubMed ID: 36825029
[TBL] [Abstract][Full Text] [Related]
10. Multidrug resistance gene expression in childhood medulloblastoma: correlation with clinical outcome and DNA ploidy in 29 patients.
Chou PM; Reyes-Mugica M; Barquin N; Yasuda T; Tan X; Tomita T
Pediatr Neurosurg; 1995; 23(6):283-91; discussion 291-2. PubMed ID: 8743996
[TBL] [Abstract][Full Text] [Related]
11. Comparison of medulloblastoma and normal neural transcriptomes identifies a restricted set of activated genes.
Boon K; Edwards JB; Siu IM; Olschner D; Eberhart CG; Marra MA; Strausberg RL; Riggins GJ
Oncogene; 2003 Oct; 22(48):7687-94. PubMed ID: 14576832
[TBL] [Abstract][Full Text] [Related]
12. Reproducibility of the NanoString 22-gene molecular subgroup assay for improved prognostic prediction of medulloblastoma.
Leal LF; Evangelista AF; de Paula FE; Caravina Almeida G; Carloni AC; Saggioro F; Stavale JN; Malheiros SMF; Mançano B; de Oliveira MA; Luu B; Neder L; Taylor MD; Reis RM
Neuropathology; 2018 Oct; 38(5):475-483. PubMed ID: 30155928
[TBL] [Abstract][Full Text] [Related]
13. Correlation of gamma-catenin expression with good prognosis in medulloblastomas.
Misaki K; Marukawa K; Hayashi Y; Fukusato T; Minamoto T; Hasegawa M; Yamashita J; Fujisawa H
J Neurosurg; 2005 Mar; 102(2 Suppl):197-206. PubMed ID: 16156230
[TBL] [Abstract][Full Text] [Related]
14. PRAME gene expression in childhood acute lymphoblastic leukemia.
Steinbach D; Viehmann S; Zintl F; Gruhn B
Cancer Genet Cytogenet; 2002 Oct; 138(1):89-91. PubMed ID: 12419593
[TBL] [Abstract][Full Text] [Related]
15. PRAME gene expression in childhood acute lymphoblastic leukemia: impact on prognosis.
Abdelmalak CA; Yahya RS; Elghannam DM; El-Khadragy AE; Abd El Messih HM
Clin Lab; 2014; 60(1):55-61. PubMed ID: 24600975
[TBL] [Abstract][Full Text] [Related]
16. Genomic and protein expression profiling identifies CDK6 as novel independent prognostic marker in medulloblastoma.
Mendrzyk F; Radlwimmer B; Joos S; Kokocinski F; Benner A; Stange DE; Neben K; Fiegler H; Carter NP; Reifenberger G; Korshunov A; Lichter P
J Clin Oncol; 2005 Dec; 23(34):8853-62. PubMed ID: 16314645
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte growth factor and sonic Hedgehog expression in cerebellar neural progenitor cells costimulate medulloblastoma initiation and growth.
Binning MJ; Niazi T; Pedone CA; Lal B; Eberhart CG; Kim KJ; Laterra J; Fults DW
Cancer Res; 2008 Oct; 68(19):7838-45. PubMed ID: 18829539
[TBL] [Abstract][Full Text] [Related]
18. Tumor associated antigen PRAME is a marker of favorable prognosis in childhood acute myeloid leukemia patients and modifies the expression of S100A4, Hsp 27, p21, IL-8 and IGFBP-2 in vitro and in vivo.
Tajeddine N; Louis M; Vermylen C; Gala JL; Tombal B; Gailly P
Leuk Lymphoma; 2008 Jun; 49(6):1123-31. PubMed ID: 18452107
[TBL] [Abstract][Full Text] [Related]
19. Rethinking medulloblastoma from a targeted therapeutics perspective.
Hashimoto Y; Penas-Prado M; Zhou S; Wei J; Khatua S; Hodges TR; Sanai N; Xiu J; Gatalica Z; Kim L; Kesari S; Rao G; Spetzler D; Heimberger A
J Neurooncol; 2018 Sep; 139(3):713-720. PubMed ID: 29869738
[TBL] [Abstract][Full Text] [Related]
20. Medulloblastoma: what is the role of molecular genetics?
Entz-Werle N; Carli ED; Ducassou S; Legrain M; Grill J; Dufour C
Expert Rev Anticancer Ther; 2008 Jul; 8(7):1169-81. PubMed ID: 18588461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
